Pharma Stocks
-
Amylyx Readies Avexitide For PBH With Pivotal Trial And Valuation Gap
Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III…
Read More » -
Is It Time To Reassess Phibro Animal Health (PAHC) After The Recent Share Price Pullback
Investors may be wondering if Phibro Animal Health at around US$43.16 is still offering value after a strong run, or…
Read More » -
Is It Too Late To Consider Johnson & Johnson (JNJ) After A 46.9% One Year Rally?
Wondering if Johnson & Johnson at around US$222 per share offers good value today, or if most of the opportunity…
Read More » -
Focus on injectable drug packaging growth
SCHOTT Pharma has reported solid first-quarter results driven by demand for injectable drug packaging, with the stock trading near its…
Read More » -
Pharma and tech group eyes growth in US markets
Merck KGaA reports solid Q1 2026 results with growth in its life science and healthcare segments, drawing attention from US…
Read More » -
Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After Its 261% One-Year Surge?
Investors may be wondering if Indivior Pharmaceuticals at US$39.60 is still offering value after its strong run, or if most…
Read More » -
Lexicon Pharmaceuticals (LXRX) Quarterly Revenue Drop Reinforces Concerns Over Persistent Losses
Lexicon Pharmaceuticals (LXRX) just closed FY 2025 with fourth quarter revenue of US$5.5 million and a basic EPS loss of…
Read More » -
Traws Pharma Stock Jumps As Biotech Targets Hantavirus After Cruise Ship Deaths
NEWTOWN, Pa., May 8, 2026, 13:12 (ET) Traws Pharma Inc. on Friday announced plans to push ahead with possible clinical…
Read More » -
Jazz Pharmaceuticals plc Just Beat Earnings Expectations: Here’s What Analysts Think Will Happen Next
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) investors will be delighted, with the company turning in some strong numbers with its latest results.…
Read More » -
Are Estimate Revisions Reshaping ANI Pharmaceuticals’ (ANIP) Earnings Narrative After Its Q1 2026 Call?
ANI Pharmaceuticals, Inc. reported its Q1 2026 results and hosted its earnings call on May 8, 2026, after pre-announcing the…
Read More »